Secondary Logo

Journal Logo

November 2018 - Volume 28 - Issue 11
pp: 245-259

Pharmacogenetic variants and response to neoadjuvant single-agent doxorubicin or docetaxel: a study in locally advanced breast cancer patients participating in the NCT00123929 phase 2 randomized trial

Ruiz-Pinto, Sara; Martin, Miguel; Pita, Guillermo; More

Pharmacogenetics and Genomics. 28(11):245-250, November 2018.

Targeted sequencing identifies a missense variant in the BEST3 gene associated with antihypertensive response to hydrochlorothiazide

Singh, Sonal; Wang, Zhiying; Shahin, Mohamed H.; More

Pharmacogenetics and Genomics. 28(11):251-255, November 2018.